Waters Completes Combination With BD Biosciences & Diagnostic Solutions via Reverse Morris Trust

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.

Waters Corporation Acquires Halo Labs

May 21, 2025

Medical Devices

Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.

MJH Life Sciences Acquires BPD Healthcare

October 22, 2025

Marketing & Advertising

MJH Life Sciences has acquired BPD Healthcare, a tech-enabled marketing and communications partner for health systems and healthcare innovators. The acquisition, completed Oct. 22, 2025 with terms undisclosed, expands MJH's capabilities in data-driven marketing, communications and strategic advisory services; WindRose Health Investors sold its stake in BPD.

Integrated Water Services and Sciens Water Acquire M|MBR Systems

January 10, 2023

Environmental Services

Integrated Water Services, in partnership with Sciens Water Opportunities Management, acquired 100% of M|MBR Systems, a membrane bioreactor (MBR) manufacturer and distributor based in Austin, Texas. The deal brings MBR manufacturing, technical expertise and the BluBox modular MBR product under IWS’s umbrella to expand capability and cross-sell solutions across water reuse and wastewater treatment markets in North America.

BD Acquires Edwards Lifesciences' Critical Care Product Group

September 3, 2024

Medical Devices

BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group and has renamed the business BD Advanced Patient Monitoring, based in Irvine, California. The deal expands BD's smart connected care portfolio with advanced monitoring technologies and AI-enabled clinical decision tools, and aligns the new unit within BD's Medical segment to enable integration with BD's infusion platforms and future closed-loop monitoring innovations.

Sherlock Biosciences Acquires Sense Biodetection

February 1, 2023

Biotechnology

Sherlock Biosciences has acquired Sense Biodetection to accelerate commercialization of CRISPR-enabled, instrument-free molecular diagnostics by integrating Sense’s Veros rapid, instrument-free test platform, chemistry and manufacturing capabilities into Sherlock’s platform. Terms were not disclosed; Sense is headquartered in Oxford, United Kingdom with additional facilities in Cambridge (UK) and Milford, Massachusetts.